Financhill
Sell
44

ATRA Quote, Financials, Valuation and Earnings

Last price:
$8.06
Seasonality move :
-1.48%
Day range:
$7.79 - $8.28
52-week range:
$5.01 - $18.71
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.35x
P/B ratio:
--
Volume:
71.5K
Avg. volume:
69.1K
1-year change:
-18.7%
Market cap:
$47.8M
Revenue:
$128.9M
EPS (TTM):
-$3.72

Earnings Data

Next earnings date for ATRA
Aug 12
2025
Most recent earnings per share
$3.50
Beat by $5.43
(May 15/2025)
Consensus Estimate
-$1.93
(May 15/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ATRA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/12/2025 Q2 $4.2M -- -- -$0.32 --
05/15/2025 Q1 $4.3M $98.1M $3.50 -$1.93 $5.43
03/07/2025 Q4 $16.6M $32.8M -$1.19 -$3.49 $2.30
11/12/2024 Q3 $35.2M $40.2M -$2.93 -$3.50 $0.57
08/12/2024 Q2 $37.1M $28.6M -$3.10 -$2.24 -$0.86
05/09/2024 Q1 $24.7M $27.4M -$5.65 -$6.42 $0.77
03/28/2024 Q4 $14.3M $4.3M -$13.92 -$12.05 -$1.87
11/01/2023 Q3 $1.3M $2.1M -$16.40 -$16.40 --
08/08/2023 Q2 $3.8M $957K -$16.91 -$16.51 -$0.40
05/08/2023 Q1 $30.7M $1.2M -$18.00 -$9.51 -$8.49
02/08/2023 Q4 -- $221K -$18.00 -- --
11/08/2022 Q3 -- $4.5M -$20.50 -- --
08/08/2022 Q2 -- $51.6M $4.50 -- --
05/05/2022 Q1 -- $7.3M -$21.75 -- --
02/28/2022 Q4 -- $7.5M -$24.00 -- --
11/04/2021 Q3 -- $5.4M -$22.50 -- --
08/09/2021 Q2 -- $3.9M -$22.75 -- --
05/04/2021 Q1 -- $3.6M -$21.50 -- --
03/01/2021 Q4 -- -- -$23.75 -- --
11/09/2020 Q3 -- -- -$23.00 -- --
08/05/2020 Q2 -- -- -$28.50 -- --
05/06/2020 Q1 -- -- -$30.00 -- --
02/27/2020 Q4 -- -- -$34.00 -- --
11/07/2019 Q3 -- -- -$32.75 -- --
08/08/2019 Q2 -- -- -$40.00 -- --
05/09/2019 Q1 -- -- -$36.00 -- --
02/26/2019 Q4 -- -- -$43.75 -- --
11/06/2018 Q3 -- -- -$32.25 -- --
08/01/2018 Q2 -- -- -$28.75 -- --
05/08/2018 Q1 -- -- -$26.25 -- --
02/27/2018 Q4 -- -- -$28.75 -- --
11/09/2017 Q3 -- -- -$25.50 -- --
08/07/2017 Q2 -- -- -$23.50 -- --
05/04/2017 Q1 -- -- -$22.00 -- --
03/09/2017 Q4 -- -- -$15.75 -- --
11/04/2016 Q3 -- -- -$22.00 -- --
08/08/2016 Q2 -- -- -$16.50 -- --
05/05/2016 Q1 -- -- -$14.50 -- --
03/03/2016 Q4 -- -- -$18.75 -- --
11/11/2015 Q3 -- -- -$10.75 -- --
08/06/2015 Q2 -- -- -$15.50 -- --

Atara Biotherapeutics Earnings Questions

  • How Much did Atara Biotherapeutics Generate in Revenue Last Quarter?

    Atara Biotherapeutics reported $98.1M worth of top line sales in its most recent quarter.

  • Did Atara Biotherapeutics Beat Earnings Last Quarter?

    Atara Biotherapeutics announced earnings per share of $3.50 which represents a beat of analyst forecast a -$1.93 per share.

  • Is Atara Biotherapeutics Profitable?

    Atara Biotherapeutics reported $77.7M that represents $7.16 per share over the last quarter.

  • What is the Analyst Consensus for Atara Biotherapeutics EPS Next Year?

    Atara Biotherapeutics's earnings are forecast to decrease from -$11.41 per share to -$4.24 per share next year representing a decrease of -49.12%.

  • When is Atara Biotherapeutics's Earnings Date?

    Atara Biotherapeutics's next earnings date is August 12, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Stellantis a Good Dividend Stock to Buy Right Now?
Is Stellantis a Good Dividend Stock to Buy Right Now?

Stellantis (NYSE: STLA) isn’t the first name most income investors think of,…

Where Will Brookfield Asset Management Stock Be In 1 Year?
Where Will Brookfield Asset Management Stock Be In 1 Year?

On a trailing basis Brookfield earned $1.60 per share over…

AMC Stock Forecast, How High Could It Go in 2025 and Beyond?
AMC Stock Forecast, How High Could It Go in 2025 and Beyond?

AMC Entertainment (NYSE:AMC) has been rising lately after years of…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 41x

Buy
59
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
37
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Buy
83
ARQQ alert for Jun 19

Arqit Quantum [ARQQ] is up 22.6% over the past day.

Sell
47
RGC alert for Jun 19

Regencell Bioscience Holdings [RGC] is down 18.36% over the past day.

Sell
49
QNTM alert for Jun 19

Quantum BioPharma [QNTM] is up 17.61% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock